+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF

Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF

Journal of the American Society of Nephrology 10(8): 1700-1708

The human vasoactive plasma factor 100KF has been proposed to play a role in minimal change disease in relapse. Since preliminary data suggested similarity between 100KF and the human plasma glycoprotein hemopexin (Hx), this study was conducted to compare 100KF with purified Hx for sequence homology, immunostaining properties in Western and dot-blot assays, ability to affect glomerular ecto-ATPase and glomerular polyanions in vitro, as well as their glomerular permeability increasing effect following alternate perfusion into the rat kidney ex vivo. 100KF was purified from normal pooled plasma according to standard chromatographic techniques, and from the same batch Hx was prepared using affinity chromatography. A second batch of Hx was prepared directly from human serum according to a standard protocol. (For comparison, additional Hx samples obtained from other centers were also included in the study.) The results show: (1) 100% homology of 100KF with plasma Hx after internal sequence analysis; (2) positive staining of the eluate with both monoclonal and polyclonal anti-Hx IgG as well as anti-100KF IgG in dot-blot assays, and similar bands on Western blotting using the same antibodies; (3) affection of glomerular polyanions and glomerular ecto-ATPase after incubation of kidney tissue with either 100KF or Hx (1.5 respectively 1.0 mg/ml; 1.0 h, 37 degrees C), as detected by computerized histochemical quantification; and (4) significant enhancement of urinary protein leakage after Hx perfusion followed by diluted rat serum into the rat kidney ex vivo (Hx: 210.65+/-49.79 microg protein leakage per min versus heat-inactivated Hx control: 112.2+/-49.18 microg per min [both n = 6]). From these data and from the observation that both Hx and 100KF activity can be inhibited by serine protease inhibitors but not by broad spectrum collagenase inhibitors, it is concluded that Hx may be closely related or identical to the active moiety of 100KF.

(PDF emailed within 1 workday: $29.90)

Accession: 010885911

Download citation: RISBibTeXText

PMID: 10446937

Related references

The vasoactive plasma factor 100KF and minimal change disease. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 85A, Sept, 1998

Enhanced glomerular and endothelial permeability induced by the human vasoactive plasma factor 100KF. Nephrology Dialysis Transplantation 10(6): 967, 1995

Induction of experimental proteinuria in rats following intrarenal infusion of 100KF. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 85A, Sept, 1998

Hemopexin-mediated heme uptake by liver. Characterization of the interaction of heme-hemopexin with isolated rabbit liver plasma membranes. Journal of Biological Chemistry 259(19): 12049-12053, 1984

Purification and immunochemical characterization of human plasma factor XIII. Haemostasis 5(6): 329-340, 1976

Description and partial characterization of the isoform pattern of complement factor H-related proteins in plasma. Molecular Immunology 44(16): 1, 2007

Effect of hemoglobin and hematin on plasma clearance of hemopexin, photo-inactivated hemopexin and albumin (38575). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 148(2): 519-522, 1975

Immunochemical characterization of the Na/H exchanger isoform NHE4 in rat. Journal of the American Society of Nephrology 5(3): 297, 1994

Immunochemical characterization of Na+/H+n exchanger isoform NHE4. American Journal of Physiology 275(4 PART 2): F510-F517, 1998

Purification and characterization of a feline plasma hemopexin. Japanese Journal of Electrophoresis 30(4): 265-272, 1986

Isoform, kinetic and immunochemical characterization of rodent liver alpha-L-fucosidases. Comparative Biochemistry and Physiology. B, Comparative Biochemistry 97(4): 713-717, 1990

Use of hemopexin domains and monoclonal antibodies to hemopexin to probe the molecular determinants of hemopexin-mediated heme transport. Journal of Biological Chemistry 263(17): 8220-8225, 1988

Conformational studies on human and rabbit plasma hemopexin and on the effect of ligands on the rabbit heme-hemopexin complex. Biochemistry 10(11): 2062-2066, 1971

Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat. Journal of Pharmacology and Experimental Therapeutics 249(3): 921-927, 1989